| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/2008 | WO2007086001A3 Novel pyridine derivatives |
| 04/03/2008 | WO2007081948A3 Bioadhesive drug formulations for oral transmucosal delivery |
| 04/03/2008 | WO2007075871A3 Processes for reducing particle size of aripiprazole |
| 04/03/2008 | WO2007070536A3 7-quinolyl ketolide antibacterial agents |
| 04/03/2008 | WO2007070359A3 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 04/03/2008 | WO2007057440A3 Improved methods of using phosphoantigen for the treatment of cancer |
| 04/03/2008 | WO2007030083A3 N-(1-pyrene)maleimide, iaans and 5- (bromomethyl) fluorescein for covalent binding to md-2 and effect on the immune response |
| 04/03/2008 | WO2007022445A8 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 04/03/2008 | WO2007021167A8 Pharmaceutical formulations in the form of solids, semisolids, in suspension, in solution, in emulsion or in syrup, containing clindamycin and one or more members of the azole family |
| 04/03/2008 | WO2007015923A8 Benzimidazoles useful as inhibitors of protein kinases |
| 04/03/2008 | WO2006114666A8 SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES |
| 04/03/2008 | US20080082156 Controlled release endoprosthetic device |
| 04/03/2008 | US20080082038 medical equipment comprising substrates having surface coatings selected from microbocidesl, antiseptics, anesthetics and anticoagulants; drug elution |
| 04/03/2008 | US20080081927 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
| 04/03/2008 | US20080081840 High protein content combined wtih carbohydrates, fats and docosahexaenoic acid; satiation feel |
| 04/03/2008 | US20080081839 Compounds useful for treating neurological disorders |
| 04/03/2008 | US20080081838 Inhibition of TNF-alpha-Initiated Neutrophil Response |
| 04/03/2008 | US20080081837 Use Of Furan Alkyl For Preparing An Antidiabetic Drug |
| 04/03/2008 | US20080081836 Anti-Tuberculosis Taxane Compounds |
| 04/03/2008 | US20080081835 Use of Ltb4 Inhibitors for the Treatment of B-Cell Leukemias and Lymphomas |
| 04/03/2008 | US20080081834 Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| 04/03/2008 | US20080081833 1-(5-cyclopropyl-2-phenyl-2H-pyrazol-3-yl)-3-(4-ethoxyphenyl)urea; 1-(5-cyclopropyl-2-phenyl-2H-pyrazol-3-yl)-3-(4-ethoxyphenyl)urea; anxiolitic and antidepressant agent; myasthenia gravis, neurodegenerative disorders, nicotine addiction |
| 04/03/2008 | US20080081832 Imidazole derivatives, processes for preparing them and their uses |
| 04/03/2008 | US20080081831 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor |
| 04/03/2008 | US20080081830 Method of treating tremors |
| 04/03/2008 | US20080081829 non-metallic substrate is coated with anesthetic having a proton binding site with a non-ionic form and an ionic form; bupivacaine, chloroprocaine, cocaine, lidocaine, mepivacaine, pramoxine and ropivacaine; sustained release the drug, adhesion to substrate, stable in aqueous environment |
| 04/03/2008 | US20080081828 Agent for Curing Chronic Obstructive Pulmonary Disease |
| 04/03/2008 | US20080081827 administering rimonabant or N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide; cannabinoid receptor antagonist for respiratory system disorders |
| 04/03/2008 | US20080081826 System for effecting weight loss |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081824 Substituted piperidines as modulators of chemokine receptor activity |
| 04/03/2008 | US20080081823 increase of the blood glucose level or decreasing the blood glucose level; enhancing insulin sensitivity or improving insulin resistance; antilipemic agents; use in foods, supplements, animal feeds; nontoxic |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081821 AZA-benzothiophenyl compounds and methods of use |
| 04/03/2008 | US20080081820 SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES |
| 04/03/2008 | US20080081819 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; glycogen synthase kinase-3 beta inhibitor; neurodegenerative disease, non-insulin dependent diabetes; inhibit amyloid precursor protein and tau protein hyperphosphorylation |
| 04/03/2008 | US20080081818 New Piperazine Compound and Use Thereof as a HCV Polymerase Inhibitor |
| 04/03/2008 | US20080081817 7-(3-ethoxybenzyl)-4-[4-[[trans-4-[[N-(2-methoxyethyl)-N-(tert-butyl)amino]methyl]cyclohexyl]carbonyl]piperazin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine; small-conductance calcium activated potassium channel (SK) blocking agent; gastrointestinal, central nervous system disorders, myotonic muscular dystrophy |
| 04/03/2008 | US20080081816 Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3 |
| 04/03/2008 | US20080081815 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists |
| 04/03/2008 | US20080081814 Carbonyl Compounds Which Can be Used as Inhibitors of Coagulation Factor Xa |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/03/2008 | US20080081811 5-[2-(cyclohexyloxy)-6-methyl-4-pyrimidinyl]-2-[5-(4-methyl-1-piperazinyl)methyl-2-pyrazinyl]amino-1,3-thiazole; anticarcinogenic agent; G1 phase in cell cycle; great selectivity |
| 04/03/2008 | US20080081810 rac-6-chloro-3-(3-chloro-benzyl)-3-(3-isopropoxy-phenylamino)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins |
| 04/03/2008 | US20080081809 Novel Compounds |
| 04/03/2008 | US20080081808 N-{4-[4-(2-{3-[(dimethylamino)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl]phenyl}-N'-phenylurea; antitumor and anticarcinogenic agent; G2 and mitotic phases in cycling cells; solid tumor and hematological cancers |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080081806 drug mixture comprising one from the group consisting of Luvox, Prozac, Zoloft, and Paxil,one from the group consisting Cialis and Viagra; nervous system disorders; Alzheimer's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Dyskinesia, Essential Dyskensia, restless leg syndrome, sleep apnea |
| 04/03/2008 | US20080081804 Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic Disorders |
| 04/03/2008 | US20080081803 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/03/2008 | US20080081802 Thiazolyl-Dihydro-Indazole |
| 04/03/2008 | US20080081801 8,13-bisvinyl-2-methyl aminocarbonylethyl-18-(3-(1-imidazolyl)propylamino)carbonyl ethyl-3,7,12,17 tetramethylporphyrin iron complex; albumin clathrate; decreases radiation resistance of hypoxic region of the tumor tissues; highly safe |
| 04/03/2008 | US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081798 Pharmaceutical combinations for the treatment of head-aches and migraine attacks as well as blisters and packs that contain them |
| 04/03/2008 | US20080081797 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
| 04/03/2008 | US20080081796 Treatment of mucositis |
| 04/03/2008 | US20080081795 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081793 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
| 04/03/2008 | US20080081791 Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi |
| 04/03/2008 | US20080081790 decrease the number of acne nodules present in the skin of the individual; side effect reduction; treating skin disorders |
| 04/03/2008 | US20080081781 Methods and compositions for the treatment of metabolic syndrome |
| 04/03/2008 | US20080081780 Identification of oligoadenylate synthetase-like genes |
| 04/03/2008 | US20080081366 Polynucleotide composition, method of preparation, and use thereof |
| 04/03/2008 | US20080081082 Topical Skin Compositions, Their Preparation, and Their Use |
| 04/03/2008 | US20080081081 Complement inhibitors; gene expression inhibition of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecular-1 (VCAM-1), and the production of nitric oxide (NO) |
| 04/03/2008 | US20080081080 Antibacterial zeolite, oil, and glutathione and/or L-cysteine; aluminum chlorhydroxide powder; washability when it has adhered to clothing |
| 04/03/2008 | US20080081078 Administering an enzyme inhibibitor to cause reduction in myosin light chain phosphorylation and to induce apoptosis in tumor cells; breast cancer, prostate cancer, lung carcinoma, renal cell carcinoma, glioma, melanoma, chemotherapy resistant tumors or metastatic tumors |
| 04/03/2008 | US20080081072 Resin-complex granulation for water-soluble drugs and associated methods |
| 04/03/2008 | US20080081070 Pharmaceutical formulation with enhanced solubility for the delivery of corticosteroids |
| 04/03/2008 | US20080081069 Novel controlled release formulations of divalproex sodium |
| 04/03/2008 | US20080081068 Modified release formulations of a bupropion salt |
| 04/03/2008 | US20080081067 First sustained release portion of core with functional coating; second portion with core and separator with functional coating; excipients; treating depressive, anxiety, and panic disorder; rate controlling polymer of ethyl acrylate, methyl methacrylate and trimethylammonioethyl methacrylate |
| 04/03/2008 | US20080081066 Reducing blood pressure byorally administering a mixture of L-theanine and a tea polyphenol such as epigallocatechol gallate; antiinflammatory and hypotensive agents; reducing low density lipoproteins |
| 04/03/2008 | US20080081065 Materials and methods for inhibiting wip1 |
| 04/03/2008 | US20080081062 Contacting medical device having surface formed from a swellable macromolecular substance with antibiotic such as isepamicin sulfate, amikacin sulfate, tobramycin, and/or kitasamycin tartrate; desolventizing |
| 04/03/2008 | US20080081060 Chitosan-coated calcium sulfate based medicament delivery system |
| 04/03/2008 | US20080081058 Composition for Promoting Vascular Smooth Muscle Relaxation |
| 04/03/2008 | US20080081053 treating acute myelogenous leukemia (AML) by administering an mTOR inhibitor (mammalian target of rapamycin); rapamycin, temsirolimus (CC1779), everolimus |
| 04/03/2008 | US20080081052 Topical compositions containing solubilized allantoin and related methods |
| 04/03/2008 | US20080081045 Combination Therapy for Cancer |
| 04/03/2008 | US20080081037 Methods and Agents for Diagnosis and Prevention, Amelioration or Treatment of Goblet Cell-Related Disorders |
| 04/03/2008 | US20080081036 Using topical mixture to repair and condition animal skin |
| 04/03/2008 | US20080081034 Topical Skin Compositions, Their Preparation, and Their Use |
| 04/03/2008 | US20080081019 Marker For Tardive Dyskinesia |
| 04/03/2008 | DE202007017517U1 Fluvastatinnatrium Fluvastatin sodium |
| 04/03/2008 | DE10226203B4 Kondensierte Palatinose, Verfahren zu deren Herstellung und deren Verwendung Condensed palatinose, processes for their preparation and their use |
| 04/03/2008 | DE102007028506A1 Cosmetic or dermatological deodorant or antitranspirant composition, useful as skin care formulation, comprises deodorant or antitranspirant active agent and dihydroquercetin in a carrier |
| 04/03/2008 | DE102006047166A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine ethyl ester and a skin moisturizer |
| 04/03/2008 | DE102006047165A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine ethyl ester and a photoprotective filter |
| 04/03/2008 | DE102006047164A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and a skin moisturizer |
| 04/03/2008 | DE102006047163A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and an antioxidant |
| 04/03/2008 | DE102006047162A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and a photoprotective filter |
| 04/03/2008 | DE102006047160A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and a filler |
| 04/03/2008 | DE102006047159A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine ethyl ester and a filler |
| 04/03/2008 | DE102006047157A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and a skin lightener |
| 04/03/2008 | DE102006047156A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine ethyl ester and a skin lightener |